Skip to main content

Peer Review reports

From: Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire

Original Submission
28 Sep 2009 Submitted Original manuscript
10 Nov 2009 Reviewed Reviewer Report - Vincent Lo Re
18 Nov 2009 Reviewed Reviewer Report - Giuseppe Lapadula
15 Dec 2009 Author responded Author comments - Koumavi Didier Ekouevi
Resubmission - Version 2
15 Dec 2009 Submitted Manuscript version 2
19 Dec 2009 Reviewed Reviewer Report - Vincent Lo Re
25 Jan 2010 Reviewed Reviewer Report - Giuseppe Lapadula
2 Mar 2010 Author responded Author comments - Koumavi Didier Ekouevi
Resubmission - Version 3
2 Mar 2010 Submitted Manuscript version 3
7 Apr 2010 Reviewed Reviewer Report - Giuseppe Lapadula
4 May 2010 Author responded Author comments - Koumavi Didier Ekouevi
Resubmission - Version 4
4 May 2010 Submitted Manuscript version 4
24 May 2010 Reviewed Reviewer Report - Giuseppe Lapadula
Resubmission - Version 5
Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
15 Jun 2010 Author responded Author comments - Koumavi Didier Ekouevi
Resubmission - Version 7
15 Jun 2010 Submitted Manuscript version 7
Resubmission - Version 8
Submitted Manuscript version 8
23 Jun 2010 Author responded Author comments - Koumavi Didier Ekouevi
Resubmission - Version 9
23 Jun 2010 Submitted Manuscript version 9
Publishing
24 Jun 2010 Editorially accepted
24 Jun 2010 Article published 10.1186/1471-2334-10-188

You can find further information about peer review here.

Back to article page